Inventor · disambiguated record
Shigekazu Nagata
Also filed as: NAGATA SHIGEKAZU
23 granted patents·3 pending applications·583 citations·filing 1989–2021
95Inventor score
Files withMOCHIDA PHARM CO LTD9OSAKA BIOSCIENCE INST7UNIV KYOTO5NAGATA SHIGEKAZU3JAPAN SCIENCE & TECH AGENCY1
Top patents by PatentIndex Score
26 records- 0190US5266491ADNA fragment and expression plasmid containing the DNA fragmentMOCHIDA PHARM CO LTD·Filed 1991·Granted Nov 30, 1993·282 cites·7 claims
- 0288US5225348ADNA fragment and expression plasmid containing the DNA fragmentMOCHIDA PHARM CO LTD·Filed 1989·Granted Jul 6, 1993·156 cites·14 claims
- 0379US6114507AAnti-Fas ligand antibody and assay method using the anti-Fas ligand antibodyMOCHIDA PHARM CO LTD·Filed 1996·Granted Sep 5, 2000·33 cites·23 claims
- 0473US8603455B2Removal promoters and inhibitor for apoptosis cells in vivoNAGATA SHIGEKAZU·Filed 2009·Granted Dec 10, 2013·1 cites·3 claims
- 0572US11692999B2Method of screening ATP11C or CDC50A inhibitorUNIV KYOTO·Filed 2021·Granted Jul 4, 2023·0 cites·3 claims
- 0671US6949360B2DNA coding for human cell surface antigenOSAKA BIOSCIENCE INST·Filed 2001·Granted Sep 27, 2005·1 cites·11 claims
- 0771US6348334B1DNA encoding Fas ligandMOCHIDA PHARM CO LTD·Filed 1994·Granted Feb 19, 2002·23 cites·25 claims
- 0871US5874546AFas antigenOSAKA BIOSCIENCE INST·Filed 1994·Granted Feb 23, 1999·23 cites·9 claims
- 0970US6897295B1Antibodies and fragments thereof to Fas ligand and Fas ligand derived polypeptidesOSAKA BIOSCIENCE INST·Filed 1996·Granted May 24, 2005·19 cites·8 claims
- 1067US8398984B2Removal promoters and inhibitor for apoptosis cells in vivoNAGATA SHIGEKAZU·Filed 2009·Granted Mar 19, 2013·0 cites·1 claims
- 1166US6953847B2Fas antigen derivativeOSAKA BIOSCIENCE INST·Filed 2001·Granted Oct 11, 2005·2 cites·20 claims
- 1264US6306395B1Fas antigen derivativesMOCHIDA PHARM CO LTD·Filed 1997·Granted Oct 23, 2001·11 cites·22 claims
- 1362US2008226556A1Removal promoters and inhibitor for apoptosis cells in vivoJAPAN SCIENCE & TECH AGENCY·Filed 2007·Application pending·0 cites
- 1461US7622554B2FAS ligand derived polypeptidesMOCHIDA PHARM CO LTD·Filed 2004·Granted Nov 24, 2009·0 cites·1 claims
- 1558US11073510B2Method of screening ATP11C or CDC50A inhibitorUNIV KYOTO·Filed 2019·Granted Jul 27, 2021·0 cites·4 claims
- 1652US9453835B2Method for screening a modulator of a TMEM16 family memberUNIV KYOTO·Filed 2013·Granted Sep 27, 2016·0 cites·5 claims
- 1750US2022233571A1Expression regulator of p2x7 receptorUNIV OSAKA·Filed 2020·Application pending·0 cites
- 1850US2006233806A1Removal promoters and inhibitor for apoptosis cells in vivoNAGATA SHIGEKAZU·Filed 2002·Application pending·0 cites
- 1949US9857357B2Method of screening modulator of XKR8UNIV KYOTO·Filed 2013·Granted Jan 2, 2018·0 cites·5 claims
- 2049US6951919B1Fas ligand derivativeMOCHIDA PHARM CO LTD·Filed 1998·Granted Oct 4, 2005·5 cites·9 claims
- 2147US10295528B2Method of screening ATP11C or CDC50A inhibitorUNIV KYOTO·Filed 2015·Granted May 21, 2019·0 cites·3 claims
- 2247US6270998B1DNA coding for human cell surface antigenOSAKA BIOSCIENCE INST·Filed 1995·Granted Aug 7, 2001·8 cites·18 claims
- 2345US5574136ADNA encoding granulocyte colony-stimulating factor receptor and protein thereofOSAKA BIOSCIENCE INST·Filed 1991·Granted Nov 12, 1996·10 cites·5 claims
- 2444US7128905B2Method of treating graft versus host disease by administration of a Fas antagonistOSAKA BIOSCIENCE INST·Filed 2002·Granted Oct 31, 2006·0 cites·3 claims
- 2542US6096312AAgent for suppressing a reduction of CD4+ lymphocytesMOCHIDA PHARM CO LTD·Filed 1998·Granted Aug 1, 2000·6 cites·4 claims
- 2634US6562342B1Preventives/remedies for inflammatory intestinal diseaseMOCHIDA PHARM CO LTD·Filed 1999·Granted May 13, 2003·3 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Shigekazu Nagata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →